Vol 5 | Issue 1 | Jan-April 2019 | page: 10-13 |Muhammad Muzzammil, Muhammad Saeed Minhas, Jahanzeb Effendi, Syed Jahanzeb, Muhammad Ovais, Azeem Jamil, Ayesha Mughal, Abdul Qadir
Author: Muhammad Muzzammil, Muhammad Saeed Minhas, Jahanzeb Effendi, Syed Jahanzeb, Muhammad Ovais, Azeem Jamil, Ayesha Mughal, Abdul Qadir
1Department of Orthopedics, Dr. Ruth K M Pfau Civil Hospital , Karachi.
2Department of Orthopedics, Jinnah Post Graduate Medical Centre, Rafiqui Shaheed Road, Karachi.
3Department of surgery, MC 7742, San Antonio.
Address of Correspondence
Dr. Muhammad Muzamil,
Department of Orthopedics, Dr. Ruth K M Pfau Civil Hospital , Karachi.
Background: In traumatic patients there is increase loss of blood and requires excessive blood transfusion as compared to other diseases. Clinical efficacy and clinical safety of tranexamic acid in decreasing blood loss assess during this study in post traumatic patients.
Method: Prospectively conducted randomized doubleblind placebo controlled study carried out. Patients were blindly randomized into two groups to receive either intravenous 1gm tranexamic acid 20 min or similar volume of 0.9% saline as placebo (P). Inclusion criteria was based on pulse rate >110 per min or systolic pressure level <90mmHg, hemorrhage or in danger of serious hemorrhage.Patients’ total blood loss was measured, needs of transfusion and hospital stay recorded. The post traumatic hemoglobin, hematocrit values, serum creatinine, activated thromboplastin time, prothombin time, platelets count and pulmonary embolism symptoms were comparatively evaluated.
Results: The total measured blood loss in tranexamic acid group (276 ± 53 mL) when comparing to control group (523 ± 74 mL) was less significantly. The requirement of blood transfusion in comparison was high in the control group and post traumatic hematocrit values were higher with in the tranexamic acid group. After administration of tranexamic acid in traumatic patients there have been no clinically relevant differences within the vital signs and no thromboembolic complications were detected in either group.
Conclusion: In traumatic patients, the prophylactic usage of tranexamic acid has effectively decreased blood loss, transfusion needs and hospital stay without any complication or adverse effects of thrombosis. Thus, TXA can be used safely and effectively in trauma subjects.
Keywords: trauma, tranexamic acid, blood loss, transfusion, hospital stay.
1. Astedt B. Clinical pharmacology of tranexamic acid. Scandinavian Journal of Gastroenterology. 1987; 22: 22–5.
2. Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, McClelland B, et al. Antifibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007;4:CD001886.
3. “Lysteda (tranexamic acid) Package Insert” (PDF). (online)(Cited 2 June 2016). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022430s004lbl.pdf.
4. Roberts I. Tranexamic acid: a recipe for saving lives in traumatic bleeding. J Tehran Heart Cent 2011; 6:178.
5. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57:1005-32.
6. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010; 376: 23–32.
7. TXA implementation pages—how to do it. (online) (Cited 2 June 2016). Available from: http://www2.le.ac.uk/departments/cardiovascular-sciences/research/population-research-and-clinical-trials/emergency-medicine-group/research/injury/txa-implementation-pages-how-to-do-it.
8. Committee on Tactical Combat Casualty Care. Tranexamic acid (TXA) in tactical combat casualty care. Guideline revision recommendation. 2011. (Online) (cited 2 June 2016). Available from: http://www.medicalsci.com/files/tranexamic_acid__txa__in_tactical_combat_casualty_care.pdf.
9. Luz L, Sankarankutty A, Passos E, Rizoli S, Fraga G, Nascimento Jr B. Tranexamic acid for traumatic hemorrhage. Rev Col Bras Cir.2012;39:77-80
10. CRASH-2 collaborators; Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011; 6:e18987.
11. Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. British Journal of Surgery 2013; 100: 1271–9.
12. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383–92.
13. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185-93.
14. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65(4):748-54.
15. Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. Br J Anaesth 2004;93:842-58
16. Godier A, Roberts I, Hunt B. Tranexamic acid: less bleeding and less thrombosis. Crit Care2012;16:135.
17. Jiménez J, Iribarren J, Lorente L, Rodríguez J, Hernandez D, Nassar I, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care2007;11:R117.
18. “The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.” The Lancet 377(9771): 1101.e1101-1101.e1102.
19. Weber, C. F., et al. “Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy.” European Journal of Anaesthesiology (EJA) 2011;28(1): 57-62
20. Bekassy Z, Astedt B. Treatment with the fibrinolytic inhibitor tranexamic acid-risk for thrombosis? ActaObstetGynecolScand1990;69:353-4.
21. World Health Organization. Injuries and violence: the facts 2014. (Online). Available from URL: http://apps.who.int/iris/bitstream/10665/149798/1/9789241508018_eng.pdf?ua=1&ua=1&ua=1
22. Murray C, Lopez A: The Global Burden of Disease. Volume 1. Cambridge, MA: Harvard University Press; 1996
23. Minhas MS, Khan KM, Effendi J, et al. Improvised explosive devise bombing police bus: Pattern of injuries, patho-physiology and early management [J]. J Pak Med Assoc, 2014, 64 ( 12 Suppl 2 ): S49-S53
24. Minhas M S, Mahmood K, Effendi J, Kumar R, Bhatti A . Terrorist Bomb Blasts: Emergency department management of multiple incidents. Trauma International July-Sep 2015;1(1): 36-40.)
25. Khan, A., et al. “Transfer delay and in-hospital mortality of trauma patients in Pakistan.” International Journal of Surgery 8(2): 155-158.
|How to Cite this article: Muzzammil M, Minhas M S, Effendi J, Jahanzeb S, Ovais M, Jamil A, Mughal A, Qadir A. The New Age of Trauma Resuscitation – Introducing Tranexamic Acid in an Accident & Emergency Department in Karachi Pakistan. Trauma International Jan-April 2019;5(1):10-13.|